ANGLE plc

LSE AGL.L

ANGLE plc Free Cash Flow Yield on January 14, 2025: -41.58%

ANGLE plc Free Cash Flow Yield is -41.58% on January 14, 2025, a -86.01% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

ANGLE plc 52-week high Free Cash Flow Yield is -20.25% on May 15, 2024, which is 51.29% above the current Free Cash Flow Yield.
ANGLE plc 52-week low Free Cash Flow Yield is -63.78% on December 20, 2024, which is -53.41% below the current Free Cash Flow Yield.
ANGLE plc average Free Cash Flow Yield for the last 52 weeks is -37.21%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

LSE: AGL.L

ANGLE plc

CEO	Mr. Andrew David William Newland ACA, Meng
IPO Date	March 17, 2004
Location	United Kingdom
Headquarters	Surrey Research Park
Employees	150
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Key trends

Past 5 years